Freestyle Libre 3 Vs Dexcom G7: 2026 CGM Comparison

Choosing between the Freestyle Libre 3 and Dexcom G7 depends on your priorities: clinical accuracy and advanced features versus affordability and simplicity. Both continuous glucose monitors represent significant advances in diabetes management technology, offering people with diabetes the freedom to monitor their glucose levels without constant fingersticks. Whether you're managing Type 1 diabetes, Type 2 diabetes on insulin, or caring for a family member with diabetes, understanding the differences between these leading CGM systems can help you make the best choice for your health needs. Doctronic's healthcare professionals can provide personalized guidance on which CGM system might work best for your specific situation.

What Are CGM Systems

Continuous glucose monitoring systems like the Freestyle Libre 3 and Dexcom G7 represent a revolutionary advancement in diabetes care technology. The Freestyle Libre 3 is Abbott's third-generation flash glucose monitoring system that provides real-time readings every minute through a small sensor worn on the upper arm. Unlike traditional blood glucose meters, this system eliminates the need for routine fingerstick calibrations while offering 14 days of continuous monitoring.

The Dexcom G7 represents the latest iteration of Dexcom's proven CGM technology, featuring an integrated transmitter design that combines the sensor and transmitter into one streamlined unit. This system also provides glucose readings every minute and maintains the 14-day sensor wear time that users expect from modern CGM technology. Both systems use different glucose measurement technologies, with the Freestyle Libre 3 utilizing enzymatic detection methods while the Dexcom G7 employs electrochemical detection to measure interstitial fluid glucose levels.

When to Choose Each System

The decision between Freestyle Libre 3 and Dexcom G7 often comes down to your specific diabetes management needs and financial considerations. Choose Freestyle Libre 3 if you're a budget-conscious user seeking reliable glucose monitoring without comprehensive insurance coverage. This system works exceptionally well for people who prefer minimal alarms and notifications during their daily activities, making it ideal for those who want discrete diabetes management.

Select Dexcom G7 for intensive insulin management that requires precise glucose trends and predictive alerts. This system suits athletes and active individuals who need customizable low and high glucose alerts during exercise or physical activity. The Dexcom G7 also integrates seamlessly with insulin pumps and automated insulin delivery systems, making it the preferred choice for people using advanced diabetes technology. Healthcare providers often recommend this system for patients requiring tight glucose control or those experiencing frequent hypoglycemic episodes.

How Both Systems Work

The Freestyle Libre 3 uses a 14-day sensor with built-in Bluetooth technology that automatically transmits glucose readings to your smartphone every minute. The sensor requires a simple insertion process using a single-use applicator that places a small filament under the skin. Once activated, the system begins providing continuous glucose data without requiring fingerstick calibrations throughout its wear period.

The Dexcom G7 combines the sensor and transmitter in one compact unit, also providing glucose readings every minute with seamless smartphone integration. Both systems require mobile app setup during initial configuration and offer cloud data sharing capabilities with healthcare providers. Installation involves inserting a small sensor filament under the skin using disposable applicators, with most users reporting minimal discomfort during the insertion process. The systems automatically sync with compatible smartphones, insulin pumps, and other diabetes management devices.

Accuracy and Performance Benefits

Clinical accuracy represents one of the most important factors when comparing CGM systems. The Dexcom G7 achieves an impressive 8.2% MARD (mean absolute relative difference) across all glucose ranges, making it one of the most accurate CGM systems available. This superior accuracy proves particularly valuable during rapid glucose changes and exercise conditions when precise readings are critical for safe diabetes management.

The Freestyle Libre 3 demonstrates a 9.2% MARD with notably improved accuracy in hypoglycemic ranges compared to its predecessor, the Libre 2. While slightly less accurate than the Dexcom G7, this system still provides clinically reliable glucose monitoring throughout its 14-day wear period. Both systems show excellent sensor reliability with minimal sensor failures, though the Dexcom G7 consistently outperforms in head-to-head accuracy studies across different user populations and glucose ranges.

Cost and Insurance Coverage Comparison

Cost considerations play a major role in CGM selection, especially for users with limited insurance coverage. The Freestyle Libre 3 costs approximately $70 per month ($35 per sensor) without insurance coverage, making it significantly more affordable than competing systems. This pricing makes continuous glucose monitoring accessible to a broader population of people with diabetes.

The Dexcom G7 averages $350 per month ($175 per sensor) at full retail pricing without insurance coverage. However, most commercial insurance plans cover 80-90% of Dexcom G7 costs compared to 60-70% coverage for Freestyle Libre 3. Medicare Part B covers both systems with a 20% copay after meeting deductible requirements, though coverage specifics vary by plan and provider.

The Bottom Line

The choice between Freestyle Libre 3 and Dexcom G7 ultimately depends on balancing your accuracy needs, budget constraints, and lifestyle preferences. Dexcom G7 leads in clinical accuracy and advanced features, making it ideal for intensive diabetes management and integration with automated insulin systems. However, the Freestyle Libre 3 provides reliable glucose monitoring at a fraction of the cost, making continuous glucose monitoring accessible to more people with diabetes. Both systems eliminate fingerstick calibrations and offer the convenience of smartphone integration. Your insurance coverage, diabetes management goals, and personal preferences should guide your decision. Ready to take control of your health? Get started with Doctronic today.